508017 Sigma-Aldrichnor-Binaltorphimine Dihydrochloride - CAS 105618-26-6 - Calbiochem
Sinónimos: Norbinaltorphimine, nor-BNI, κ Opioid Receptor Antagonist, nor-Binaltorphimine
Productos recomendados
Descripción
| Replacement Information |
|---|
Tabla espec. clave
| CAS # | Empirical Formula |
|---|---|
| 105618-26-6 | C₄₀H₄₃N₃O₆·2HCl |
Precios y disponibilidad
| Número de referencia | Disponiblidad | Embalaje | Cant./Env. | Precio | Cantidad | |
|---|---|---|---|---|---|---|
| 5.08017.0001 |
|
Frasco de vidrio | 10 mg |
|
— |
| References | |
|---|---|
| References | Kishioka, S., et al. 2013. Neurosci. Letters. In press. Valdez, G., et al. 2012. Pharma. Biochem. and Behavior. 102, 44. Takemori AE et al. 1988. J. Pharmacol. Exp. Ther. 246, 255. |
| Product Information | |
|---|---|
| CAS number | 105618-26-6 |
| Form | White to off-white solid |
| Hill Formula | C₄₀H₄₃N₃O₆·2HCl |
| Chemical formula | C₄₀H₄₃N₃O₆·2HCl |
| HS Code | 2939 79 90 |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | kappa opioid receptor |
| Purity | ≥98% by HPLC |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Número de referencia | GTIN |
| 5.08017.0001 | 04055977242775 |
Documentation
nor-Binaltorphimine Dihydrochloride - CAS 105618-26-6 - Calbiochem Ficha datos de seguridad (MSDS)
| Título |
|---|
nor-Binaltorphimine Dihydrochloride - CAS 105618-26-6 - Calbiochem Certificados de análisis
| Cargo | Número de lote |
|---|---|
| 508017 |
Referencias bibliográficas
| Visión general referencias |
|---|
| Kishioka, S., et al. 2013. Neurosci. Letters. In press. Valdez, G., et al. 2012. Pharma. Biochem. and Behavior. 102, 44. Takemori AE et al. 1988. J. Pharmacol. Exp. Ther. 246, 255. |



